Angimmune
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
15601 Crabbs Branch Way, Rockville, Mary...Phone Number
(508) 397-8150Website
www.angimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Angimmune
Angimmune LLC is a biotechnology company focused on developing Resimmune, a high potency anti-CD3 immunotoxin for the treatment of Cutaneous T-Cell Lymphoma (CTCL) and other T cell-driven diseases. The company aims to provide innovative immunotherapeutic solutions for cancer, autoimmune diseases, and organ transplant rejection prevention. Resimmune has shown potential in inducing anti-tumor immune responses and is being investigated for its applications in immuno-oncology and transplantation. Angimmune is open to collaborations and licensing opportunities to further advance its proprietary technology.Explore more
Angimmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Angimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Angimmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Angimmune
Website visits: Recent activity has been detected on your website
Check if Angimmune has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Angimmune has new funding data
Angimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Angimmune launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Angimmune is spiking on competitors!
Click to see if Angimmune had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Angimmune
Find more new buyers
Compare Similar Companies to Angimmune
Compare insights from companies similar to Angimmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2016
KC
Kellie CalderonDivision Clinical Development Vice President, Medical Affairs
Company Profile Activity
Activity Insights
Angimmune is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Angimmune is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Angimmune.
Angimmune Tech Stack
A closer look at the technologies used by Angimmune
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Angimmune
Sign Up For FreeTo access detailed company insights
Angimmune LLC is a biotechnology company focused on developing Resimmune, a high potency anti-CD3 immunotoxin for the treatment of Cutaneous T-Cell Lymphoma (CTCL) and other T cell-driven diseases. The company aims to provide innovative immunotherapeutic solutions for cancer, autoimmune diseases, and organ transplant rejection prevention. Resimmune... Read More
